A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

Clinical trial NCT07609914 · RECRUITING

Trial details

NCT number: NCT07609914
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Treatment of Migraine

Start date: 2026-05-28
Primary completion: 2028-05-15
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.